Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tenapanor Formulations in Healthy Volunteers Taking Omeprazole
NCT02249936Phase 1Completed
- Sponsor
- Ardelyx
- Start
- Feb 2013
- Primary completion
- Feb 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of tenapanor in irritable bowel syndrome (IBS) and hyperphosphatemia (3 arms), sponsored by Ardelyx. Primary endpoint: Adverse events at 8 days. Started Feb 2013; status: completed.
02
Drugs
tenapanor
03
Conditions
irritable bowel syndrome (IBS)hyperphosphatemia
Beyond the preview
Go deeper on NCT02249936.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02249936.